MESA, AZ--(Marketwired - December 02, 2013) - Ulthera
, Inc. -- a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications -- today announced it will be participating in the 25th Annual Piper Jaffray
Healthcare Conference in New York on Dec. 3-4, 2013.
Ulthera is scheduled to present on Tuesday, Dec. 3, 2013 at 4:30 pm EST at the New York Palace Hotel.
The Piper Jaffray Healthcare Conference will feature senior management teams from 250 leading public and private companies delivering presentations to more than 1,500 institutional investors, equity portfolio managers and research analysts.
Ulthera, Inc. is a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive U.S. FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is cleared to lift skin above the brow, on the neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top-tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ultherapy.com.